According to Omeros Corporation's latest financial reports the company's total debt is C$0.27 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | C$0.46 B | 4.69% |
2021-12-31 | C$0.44 B | 29.32% |
2020-12-31 | C$0.34 B | 35.26% |
2019-12-31 | C$0.25 B | 22.84% |
2018-12-31 | C$0.20 B | 93.94% |
2017-12-31 | C$0.10 B | -0.7% |
2016-12-31 | C$0.10 B | 54.93% |
2015-12-31 | C$69.14 M | 83.59% |
2014-12-31 | C$37.66 M | 72.6% |
2013-12-31 | C$21.82 M | 9.15% |
2012-12-31 | C$19.99 M | 1.06% |
2011-12-31 | C$19.78 M | 102.85% |
2010-12-31 | C$9.75 M | -27.36% |
2009-12-31 | C$13.42 M | -33.79% |
2008-12-31 | C$20.27 M | 1912.15% |
2007-12-31 | C$1 M |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Eterna Therapeutics ERNA | C$3.94 M | -98.59% | ๐บ๐ธ USA |
![]() Genetic Technologies GENE | C$0.8 M | -99.71% | ๐ฆ๐บ Australia |
![]() Pfizer PFE | C$83.80 B | 29,961.55% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | C$71.44 B | 25,528.17% | ๐บ๐ธ USA |